Six of One - Obamacare over the Affordable Care Act
Undoubtedly, Obamacare has good intentions for a national health care system in the US The United States should clearly provide health care from the cradle to the grave, just as it is in most countries Europe, including France, however, in order to fully achieve this, Obamacare must be optimized and a number of reforms are necessary that we label as Manifesto for health care reform in the United States more Health in order to properly assess the reforms needed to improve the current system Obamacare, it is critical to compare Obamacare to the French health care system is considered by the world health Organization as the country with the best health care system in the world.
Obviously, Obamacare is a first step and has already caused the annual increase in health care costs to slow All thanks to in 2012, in 2010 the law, for example the president, health care costs have increased 4 less than half the rate of only there about ten years, however, this decline in the annual increase in costs is not sufficient to cure the health care cost problem in absolute terms is simply not affordable, the annual cost of a family health plan is approximately 16351 which is economically unaffordable for most families the cost of health care would have to be reduced in absolute terms to coincide with the cost of health care French.
To resolve this issue with the health care system, we must first clearly define the problem first and foremost, a major problem in the health care industry in the United States is the spiraling costs that took effect in the 80 and surpassed all other costs, including the consumer price index as shown in Figure 1 shown below as seen in the graph, the five components of health care costs exceeded the average consumer price index that the annual rate of increase in costs outpaced the overall economy thereafter, it is causing a prohibitive increase in consumer costs and care corporate health, and the annual deficit of the US budget and the national debt on the basis of these results, it seems very likely that the private health care industry is the culprit he simply acted as a monopoly and exploited the inelasticity of demand for health care and raises prices.
To further support this argument, sending healthcare data can be used to compare the United States to France first, it can be identified that pharmaceutical expenditure in 2010 in the United States was raised to 983 USD per capita at current prices and PPPs drug expenditure per capita in comparison, in France, expenditure was USD 634 per capita at current prices and PPPs drug expenditure per capita This is a clear indicator that drug costs are higher in the States States than in France This may be explained by two key facts.
The first is that the United States, health care services are paid different amounts depending on the health plan patients This automatically gives the room health care providers to discriminate between patients and only select the drug with higher costs out of pocket further, the system in the United States are not very flexible with regard to the determination of the cost of medicines and health services changing health care rates, as with 'insurance, currently have to obtain approval by Congress before it can take effect this is a cumbersome process, which slows down the ability to respond quickly to market needs.
France is also distinguished in their approach to the regulation of the cost of health care services in their countries France has an organization called the CNAMTS that monitor spending of services throughout the country if the expenses for some type of drug or a service increases in a particular area, CNAMTS have the power to go and cut the price of the drug or service to make it more accessible and facilitate supply to meet the market needs in conjunction with this living system, France has also set up a common fee schedule in the country that requires health services offer a standard price for the procedures, regardless of health insurance policies.
However, there is no provision in the Affordable Care Act that requires a system like in France to implement the US While Obamacare sought a more equitable solution to the health system America, he fell short of reaching the bureaucratic efficiency status quo of administrative costs for private insurance companies are nearly three times the cost in France 5 France 14 US and Obamacare are not structured to cut costs effectively to obtain a more optimal result, the United States can use Medicare as a precedent to mimic hover below the cost of the France administrative costs from Medicare to 3 6 of the total expenditure Revises Obamacare implementing Medicare administrative practices can greatly help untangling the medical bureaucracy, reduce operating costs and simplif ier experience for the consumer.
For the United States to reflect the French health system, it is also essential for the United States to implement a policy to begin reducing the costs associated with the administration of the medical payment system This could easily be accomplished using a health insurance system for all citizens Moreover, for all additional costs not covered by the universal health insurance system, patients should be allowed to carry additional insurance, similar to Medi-gap France found it very effective to use insurance programs to provide missing services are not covered in their universal program again, the United States needs to implement aggressive negotiation with government hospitals, laboratories pharmaceuticals and doctors France has focused on negotiation, while the United States lack nt much in this area in some cases, the US government is even forbidden to implement the trading system Such an example with insurance prescription Part D Medicare explicitl The US government is prohibited from trading there lower cost drugs associated with Medicare Part D.
By emulating the French cost and quality of health care in the United States, the private sector in health care will have to become efficient and competitive Otherwise, price controls and other regulatory measures may be imposed to solve the problem and the consequences of these approaches are very wide and deep in ideological terms it can end the insurance companies of private health care and impose strict controls on the prices of pharmaceuticals, hospitals and doctors in other words, providers in the health care industry should be considered as a natural monopoly, and therefore must be controlled just as utility prices are currently controlled through a performance cost formula It is reasonable to act no alternative to the United States, except to return to the mid-80s and adjust the costs of health care or down to match the health care costs of the French system.
Other elements of the Manifesto for the reform of the US health care include changing the culture and attitudes of doctors The same rule should apply to hospitals and drug manufacturers rather than putting all the emphasis on the become capitalists and successful entrepreneurs in the health care, they should be more emphasis on primary loyalty and responsibility to patient care, for example, in France the wages of the average primary care physician was 95,892 by compared to 186,582 in the US, almost double for a doctor providing the same services, but doctors in France are required to complete on average years of medical school while remaining true to patients the honor of being a doctor in France is above and beyond business objectives, as is clearly demonstrated their acceptance of a reasonable salary.
While Obamacare can not be reproduced the health care system in French, it seems that its goals are similar, but unfortunately remain unaffordable Therefore, it is necessary that policies to promote the goals and make them affordable Adopting political solve the problems mentioned above described in terms of the Manifesto for US healthcare reform, and creating a health insurance program for all citizens through the affordable care Act, is Obama can to reduce the cost of health care to the public and make it more accessible and to increase the number of US citizens who may have access to universal health care.
M Nake Kamrany is professor of economics at the University of Southern California and director of the Program in Law and Economics and member of the California Bar Jessica Greenhalgh is a student in economics and biological sciences at the University of Southern California, and convergence Group's research partner global income ICGG in Los Angeles.
Obamacare vs., Obamacare, health care system, the cost of health care.